Arno Therapeutics, Inc
company.status.inactiveCIK 1195116fmd_0D433RFGX7H4HNZAA9HVZXHYMAManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2006 to Sep 30, 2016, 30 periods
| Line item | FY2006 | FY2007 | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | – | – | – | – | 4 | 6 | 9 | 13 | 15 | 9 |
| Total operating expenses | – | – | – | – | 5 | 8 | 11 | 17 | 21 | 13 |
| Operating income | – | – | – | – | (5) | (8) | (11) | (17) | (21) | (13) |
| Interest expense | – | – | – | – | – | 0 | 6 | 19 | 0 | 0 |
| Interest and investment income | – | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | – | – | – | 1 | (0) | (4) | (23) | 29 | 2 |
| Income tax expense | – | – | – | – | – | – | – | – | 0 | 0 |
| Net income | (0) | (3) | (13) | (7) | (4) | (8) | (14) | (40) | 8 | (12) |
| Net income to common shareholders | – | – | – | – | (4) | (8) | (14) | – | – | – |